Catalent
CTLT
#1737
Rank
โ‚ฌ9.89 B
Marketcap
54,52ย โ‚ฌ
Share price
0.00%
Change (1 day)
3.45%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ5.29 Billion

According to Catalent's latest financial reports the company's total liabilities are โ‚ฌ5.29 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30โ‚ฌ5.64 B3.24%
2022-06-30โ‚ฌ5.47 B34.1%
2021-06-30โ‚ฌ4.08 B7.34%
2020-06-30โ‚ฌ3.80 B10.89%
2019-06-30โ‚ฌ3.42 B16.47%
2018-06-30โ‚ฌ2.94 B22.98%
2017-06-30โ‚ฌ2.39 B8.25%
2016-06-30โ‚ฌ2.21 B-1.71%
2015-06-30โ‚ฌ2.24 B-11.04%
2014-06-30โ‚ฌ2.52 B-2.07%
2013-06-30โ‚ฌ2.58 B-6.35%
2012-06-30โ‚ฌ2.75 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Supernus Pharmaceuticals
SUPN
โ‚ฌ0.31 B-94.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.46 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚ฌ6.35 B 19.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚ฌ0.27 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA